STAT3 regulated ATR via microRNA-383 to control DNA damage to affect apoptosis in A431 cells

Cellular Signalling

Volumn 27, Issue 11, 2015, Pages 2285-2295

  Liao, Xing Hua ^a,b   Zheng, Li ^a   He, Hong Peng ^a   Zheng, De Liang ^a   Wei, Zhao Qiang ^a   Wang, Nan ^a   Dong, Jian ^b   Ma, Wen Jian ^a   Zhang, Tong Cun ^a,b  

^a TIANJIN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b WUHAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

ATR; DNA damage; MiR 383; Skin cancer; STAT3

Indexed keywords

ATR PROTEIN; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 45; HISTONE H2AX; MICRORNA; MICRORNA 383; STAT3 PROTEIN; UNCLASSIFIED DRUG; 3' UNTRANSLATED REGION; ATM PROTEIN; ATR PROTEIN, HUMAN; CELL CYCLE PROTEIN; CYCLIN D1; GADD45A PROTEIN, HUMAN; H2AFX PROTEIN, HUMAN; HISTONE; MCL1 PROTEIN, HUMAN; MDC1 PROTEIN, HUMAN; MIRN383 MICRORNA, HUMAN; NUCLEAR PROTEIN; PROTEIN MCL 1; STAT3 PROTEIN, HUMAN; TRANSACTIVATOR PROTEIN;

3' UNTRANSLATED REGION; A431 CELL LINE; APOPTOSIS; ARTICLE; BCL 1 GENE; CANCER CELL LINE; CANCER PREVENTION; CANCER THERAPY; CONTROLLED STUDY; DNA DAMAGE; DOWN REGULATION; GENE; GENE TARGETING; GENETIC TRANSCRIPTION; HISTONE PHOSPHORYLATION; HUMAN; HUMAN CELL; LUCIFERASE ASSAY; MCL 1 GENE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; SKIN CANCER; SQUAMOUS CELL CARCINOMA; ULTRAVIOLET RADIATION; UPREGULATION; ADVERSE EFFECTS; BIOSYNTHESIS; DNA REPAIR; ENZYME ACTIVATION; GENETICS; METABOLISM; PHOSPHORYLATION; SKIN TUMOR; TUMOR CELL LINE;

3' UNTRANSLATED REGIONS; APOPTOSIS; ATAXIA TELANGIECTASIA MUTATED PROTEINS; CELL CYCLE PROTEINS; CELL LINE, TUMOR; CYCLIN D1; DNA DAMAGE; DNA REPAIR; ENZYME ACTIVATION; HISTONES; HUMANS; MICRORNAS; MYELOID CELL LEUKEMIA SEQUENCE 1 PROTEIN; NUCLEAR PROTEINS; PHOSPHORYLATION; PROMOTER REGIONS, GENETIC; SKIN NEOPLASMS; STAT3 TRANSCRIPTION FACTOR; TRANS-ACTIVATORS; ULTRAVIOLET RAYS;

EID: 84941260429     PISSN: 08986568     EISSN: 18733913     Source Type: Journal    
DOI: 10.1016/j.cellsig.2015.08.005     Document Type: Article

References (40)

1. Sng J., Koh D., Siong W.C., Choo T.B. Skin cancer trends among Asians living in Singapore from 1968 to 2006. J. Am. Acad. Dermatol. 2009, 61:426-432.
2. Liu Y., Liu M., Xiao H., Cai J., Xu W. A content analysis of news coverage of skin cancer in China newspapers. Health Commun. 2010, 25:647-649.
3. Rouse J., Jackson S.P. Interfaces between the detection, signaling and repair of DNA damage. Science 2002, 297:547-551.
4. Syljuasen R.G., Sorensen C.S., Hansen L.T., Fugger K., Lundin C., Johansson F., et al. Inhibition of human Chk1 causes increased initiation of DNA replication, phosphorylation of ATR targets, and DNA breakage. Mol. Cell. Biol. 2005, 25:3553-3562.
5. Zou L. Single- and double-stranded DNA: building a trigger of ATR-mediated DNA damage response. Genes Dev. 2007, 21(8):879-885.
6. Cliby W.A., Roberts C.J., Cimprich K.A., Stringer C.M., Lamb J.R., Schreiber S.L., et al. Overexpression of a kinase-inactive ATR protein causes sensitivity to DNA-damaging agents and defects in cell cycle checkpoints. EMBO J. 1998, 17:159-169.
7. Lu Y.P., Lou Y.R., Yen P., Mtichell D., Huang M.T., Conney A.H. Time course for early adaptive responses to ultraviolet B light in the epidermis of SKH-1 mice. Cancer Res. 1999, 59:4591-4602.
8. Bowman T., Garcia R., Turkson J., Jove R. STATs in oncogenesis. Oncogene 2000, 19:2474-2488.
9. Alvarez J.V., Febbo P.G., Ramaswamy S., Loda M., Richardson A., Frank D.A. Identification of a genetic signature of activated signal transducer and activator of transcription 3 in human tumors. Cancer Res. 2005, 65:5054-5062.
10. Chan K.S., Carbajal S., Kiguchi K., Clifford J., Sano S., DiGiovanni J. Epidermal growth factor receptor mediated activation of Stat3 during multistage skin carcinogenesis. Cancer Res. 2004, 64:2382-2389.
11. Farazi A.T., Juranek A.S., Tuschl T. The growing catlog of small RNAs and their association with distinct Argonaute/Piwi family members. Development 2008, 135:1201-1214.
12. Bartel D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116:281-297.
13. Wei W., Ba Z., Gao M., Wu Y., Ma Y., Amiard S., et al. A role for small RNAs in DNA double-strand break repair. Cell 2012, 149:101-112.
14. Chen C.Z. MicroRNAs as oncogenes and tumor suppressors. N. Engl. J. Med. 2005, 353:1768-1771.
15. Wang J., He J., Su F., Ding N., Hu W., Yao B., et al. Repression of ATR pathway by miR-185 enhances radiation-induced apoptosis and proliferation inhibition. Cell Death Dis. 2013, 4:e699.
16. Liao X.H., Wang N., Liu Q.X., Qin T., Cao B., Cao D.S., et al. Myocardin-related transcription factor-A induces cardiomyocyte hypertrophy. IUBMB Life 2011, 63:54-56.
17. Wang N., Xie K., Huo S., Zhao J., Zhang S., Miao J. Suppressing phosphatidylcholine-specific phospholipase C and elevating ROS level, NADPH oxidase activity and Rb level induced neuronal differentiation in mesenchymal stem cells. J. Cell. Biochem. 2007, 100:1548-1557.
18. Latha K., Zhang W., Cella N., Shi H.Y., Zhang M. Maspin mediates increased tumor cell apoptosis upon induction of the mitochondrial permeability transition. Mol. Cell. Biol. 2005, 25:1737-1748.
19. Zhang W., Bae I., Krishnaraju K., Azam N., Fan W., Smith K., et al. CR6: a third member in the MyD118 and Gadd45 gene family which functions in negative growth control. Oncogene 1999, 18:4899-4907.
20. Smith M.L., Kontny H.U., Zhan Q., Sreenath A., O'Connor P.M., Fornace A.J. Antisense GADD45 expression results in decreased DNA repair and sensitizes cells to U.V.-irradiation or cisplatin. Oncogene 1996, 13:2255-2263.
21. Stewart G.S., Wang B., Bignell C.R., Taylor A.M., Elledge S.J. MDC1 is a mediator of the mammalian DNA damage checkpoint. Nature 2003, 42:961-966.
22. Barry S.P., Townsend P.A., Knight R.A., Scarabelli T.M., Latchman D.S., Stephanou A. STAT3 modulates the DNA damage response pathway. Int. J. Exp. Pathol. 2010, 91:506-514.
23. Zou L., Elledge S.J. Sensing DNA damage through ATRIP recognition of RPA-ssDNA complexes. Science 2003, 300:1542-1548.
24. Huang H., Tian H., Duan Z., Cao Y., Zhang X.S., Sun F. microRNA-383 impairs phosphorylation of H2AX by targeting PNUTS and inducing cell cycle arrest in testicular embryonal carcinoma cells. Cell. Signal. 2014, 26:903-911.
25. Bromberg J., Darnell J.E. The role of STATs in transcriptional control and their impact on cellular function. Oncogene 2000, 19:2468-2473.
26. O'Shea J.J., Holland S.M., Staudt L.M. JAKs and STATs in immunity, immunodeficiency, and cancer. Oncogene 2000, 19:2474-2488.
27. Chan K.S., Sano S., Kiguchi K., Anders J., Komazawa N., Takeda J., et al. Disruption of Stat3 reveals a critical role in both the initiation and the promotion stages of epithelial carcinogenesis. J. Clin. Invest. 2004, 114:720-728.
28. Kim D.J., Angel J.M., Sano S., DiGiovanni J. Constitutive activation and targeted disruption of signal transducer and activator of transcription 3 (Stat3) in mouse epidermis reveal its critical role in UVB-induced skin carcinogenesis. Oncogene 2009, 28:950-960.
29. Sano S., Chan K.S., Kira M., Kataoka K., Takagi S., Tarutani M., et al. Signal transducer and activator of transcription 3 is a key regulator of keratinocyte survival and proliferation following UV irradiation. Cancer Res. 2005, 65:5720-5729.
30. Boehm A.L., Sen M., Seethala R., Gooding W.E., Freilino M., Wong S.M., et al. Combined targeting of epidermal growth factor receptor, signal transducer and activator of transcription-3, and Bcl-XL enhances antitumor effects in squamous cell carcinoma of the head and neck. Mol. Pharmacol. 2008, 73:1632-1642.
31. Koganti S., Hui-Yuen J., McAllister S., Gardner B., Grasser F., Palendira U., et al. STAT3 interrupts ATR-Chk1 signaling to allow oncovirus-mediated cell proliferation. Proc. Natl. Acad. Sci. U. S. A. 2014, 111(13):4946-4951.
32. Liu S., Shiotani B., Lahiri M., Maréchal A., Tse A., Leung C.C., et al. ATR autophosphorylation as a molecular switch for checkpoint activation. Mol. Cell 2011, 43:192-202.
33. Tian H., Cao Y.X., Zhang X.S., Liao W.P., Yi Y.H., Lian J., et al. The targeting and functions of miRNA-383 are mediated by FMRP during spermatogenesis. Cell Death Dis. 2013, 4:e617.
34. Yin M., Lü M., Yao G., Tian H., Lian J., Liu L., et al. Transactivation of microRNA-383 by steroidogenic factor-1 promotes estradiol release from mouse ovarian granulosa cells by targeting RBMS1. Mol. Endocrinol. 2012, 26:1129-1143.
35. Aoki Y., Feldman G.M., Tosato G. Inhibition of STAT-3 signaling induces apoptosis and decreases survivin expression in primary effusion lymphoma. Blood 2003, 101:1535-1542.
36. Grandis J.R., Drenning S.D., Zeng Q., Watkins S.C., Melhem M.F., Endo S., et al. Constitutive activation of STAT-3 signaling abrogates apoptosis in squamous cell carcinogenesis in vivo. Proc. Natl. Acad. Sci. 2000, 97:4227-4232.
37. Enk C.D., Jacob-Hirsch J., Gal H., Verbovetski I., Amariglio N., Mevorach D., et al. The UVB-induced gene expression profile of human epidermis in vivo is different from that of cultured keratinocytes. Oncogene 2006, 25:2601-2614.
38. Kulms D., Schwarz T. Independent contribution of three different pathways to ultraviolet-B-induced apoptosis. Biochem. Pharmacol. 2002, 64:837-841.
39. Haura E.B., Turkson J., Jove R. Mechanisms of disease: insights into the emerging role of signal transducers and activators of transcription in cancer. Nat. Clin. Pract. Oncol. 2005, 2:315-324.
40. Song J.I., Grandis J.R. STAT signaling in head and neck cancer. Oncogene 2000, 19:2489-2495.